Apotex Health files preliminary prospectus for initial public offering of shares

Apotex workers are shown in Toronto on Friday, April 9, 2021. THE CANADIAN PRESS/Nathan Denette

TORONTO — Apotex Health Corp. says it has filed a preliminary prospectus for an initial public offering that will see the Canadian generic drug company join the public market.

The Toronto-based company says the plan includes a treasury offering of shares and a secondary offering by certain shareholders, including SK Capital Partners, the company’s controlling shareholder.

Apotex says it has applied to list the shares on the Toronto Stock Exchange.

• Latest updates on company news here

The number of shares to be offered and the price have not yet been determined.

Apotex has a broad portfolio of generic drugs and consumer health products.

It has operations in Canada, the U.S., Mexico and India.

This report by The Canadian Press was first published May 28, 2026.